Venture designed to streamline drug development and clinical trials.
Synthetica Bio, a healthcare technology company focused on the development of generative artificial intelligence (AI), has officially announced its launch and continued venture funding. With funding led by Virtue, and additional support provided by AIX Ventures and Page One Ventures, proceeds are expended to support development of the Synthetica Bio platform. The organization’s overall goal is to provide actionable knowledge to biopharma companies to drive drug development, clinical trials, and commercial activity in a safe and efficient manner.
"By democratizing access to insights from healthcare data we enable healthcare information workers to do their job more effectively, and in a more secure manner," said Simon Arkell, CEO. Synthetica Bio. "Our early partners are already addressing bottlenecks in commercial targeting with our unique 'co-pilot' approach to address the analytics bottlenecks that slow everyone down. While the healthcare data industry is now providing massive data feeds from diverse sources, the analytics remain outdated, necessitating large teams for even basic queries. Our platform will streamline this process while providing data privacy as a key tenet."
Reference: Synthetica Bio Launches with Venture Funding to Develop a Generative AI Platform Purpose-Built for Biopharma. PR Newswire. June 27, 2023. Accessed June 28, 2023. https://www.prnewswire.com/news-releases/synthetica-bio-launches-with-venture-funding-to-develop-a-generative-ai-platform-purpose-built-for-biopharma-301864054.html
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
Trends in Continuing Medical Education
April 12th 2024Elliott Yoo, Senior Media Strategist at epocrates, takes a closer look at the trends in CME consumption and what the future of medical education will be – from the priorities for physicians as they juggle learning with patient care, to what type of activities resonate most with prescribers.
Beyond the Scrubs: Understanding Healthcare Providers as People for Increased Engagement
March 28th 2024The benefits of adopting a humanized approach to healthcare provider marketing extend across the healthcare spectrum, enhancing engagement rates, brand loyalty, and marketing ROI, while also driving better outcomes for patients.